Search Results - "STERNBERG, D. W"

Refine Results
  1. 1

    KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32) by LEVINE, R. L, WADLEIGH, M, STERNBERG, D. W, WLODARSKA, I, GALINSKY, I, STONE, R. M, DEANGELO, D. J, GILLILAND, D. Gary, COOLS, J

    Published in Leukemia (2005)
    “…We report the cloning of a novel PDGFRB fusion gene partner in a patient with a chronic myeloproliferative disorder characterized by t(5;14)(q33;q32), who…”
    Get full text
    Journal Article
  2. 2

    Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation by Frantsve, Julie, Schwaller, Juerg, Sternberg, David W., Kutok, Jeffery, Gilliland, D. Gary

    Published in Molecular and Cellular Biology (01-05-2001)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  3. 3
  4. 4

    K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity by Berg, M M, Sternberg, D W, Parada, L F, Chao, M V

    Published in The Journal of biological chemistry (05-01-1992)
    “…The rat pheochromocytoma PC12 cell line differentiates into a sympathetic neuronal phenotype upon treatment with either nerve growth factor (NGF) or basic…”
    Get full text
    Journal Article
  5. 5

    The Low-Affinity p75 Nerve Growth Factor (NGF) Receptor Mediates NGF- Induced Tyrosine Phosphorylation by Berg, Margaret M., Sternberg, David W., Hempstead, Barbara L., Chao, Moses V.

    “…Protein tyrosine phosphorylation is a potential mechanism for initial signaling in PC12 cells during differentiation in response to nerve growth factor (NGF)…”
    Get full text
    Journal Article
  6. 6

    Combination of Rapamycin and Protein Tyrosine Kinase (PTK) Inhibitors for the Treatment of Leukemias Caused by Oncogenic PTKs by Mohi, M. Golam, Boulton, Christina, Gu, Ting-Lei, Sternberg, David W., Neuberg, Donna, Griffin, James D., Gilliland, D. Gary, Neel, Benjamin G., Ruderman, Joan V.

    “…Abnormal protein tyrosine kinases (PTKs) cause many human leukemias. For example, BCR/ABL causes chronic myelogenous leukemia (CML), whereas FLT3 mutations…”
    Get full text
    Journal Article
  7. 7

    Nerve Growth Factor Stimulates Protein Tyrosine Phosphorylation in PC-12 Pheochromocytoma Cells by Miyasaka, Tadayo, Sternberg, David W., Miyasaka, Junko, Sherline, Peter, Saltiel, Alan R.

    “…The cellular actions of nerve growth factor (NGF) and epidermal growth factor (EGF) may be mediated by changes in protein phosphorylation. The tyrosine…”
    Get full text
    Journal Article
  8. 8

    Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine : A pharmacologically based regimen by STERNBERG, D. W, AIRD, W, NEUBERG, D, THOMPSON, L, MACNEILL, K, AMREIN, P, SHULMAN, L. N

    Published in Cancer (01-05-2000)
    “…Although chemotherapy can achieve a high rate of disease remission induction in patients with newly diagnosed acute myelogenous leukemia (AML), patients with…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Activation of a histone H1 kinase by tyrosine phosphorylation in v‐src‐transformed fibroblasts by Sternberg, D.W., Scholz, G., Fukui, Y., Hanafusa, H.

    Published in The EMBO journal (01-01-1993)
    “…Using anti‐phosphotyrosine immunoaffinity chromatography, we have searched for serine/threonine kinases that are directly regulated by tyrosine phosphorylation…”
    Get full text
    Journal Article
  11. 11

    S-methyl glutathione synthesis is catalyzed by the cheR methyltransferase in Escherichia coli by TERWILLIGER, T. C, BOLLAG, G. E, STERNBERG, D. W. JR, KOSHLAND, D. E. JR

    Published in Journal of Bacteriology (01-03-1986)
    “…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Quantitative Proteomic Analysis Using Isobaric Protein Tags Enables Rapid Comparison of Changes in Transcript and Protein Levels in Transformed Cells by Unwin, Richard D, Pierce, Andrew, Watson, Rod B, Sternberg, David W, Whetton, Anthony D

    Published in Molecular & cellular proteomics (01-07-2005)
    “…Isobaric tags for relative and absolute quantitation, an approach to concurrent, relative quantification of proteins present in four cell preparations, have…”
    Get full text
    Journal Article
  15. 15

    NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a by Gu, Ting-Lei, Tothova, Zuzana, Scheijen, Blanca, Griffin, James D., Gilliland, D. Gary, Sternberg, David W.

    Published in Blood (15-06-2004)
    “…Between 30% and 50% of patients with advanced-stage anaplastic large-cell lymphoma (ALCL) harbor the balanced chromosomal rearrangement t(2;5)(p23;q35), which…”
    Get full text
    Journal Article
  16. 16

    The Role of Signal Transducer and Activator of Transcription Factors in Leukemogenesis by STERNBERG, David W, GILLILAND, D. Gary

    Published in Journal of clinical oncology (15-01-2004)
    “…Human leukemias are frequently associated with the aberrant expression of activated fusion tyrosine kinases or activated protein tyrosine kinases carrying…”
    Get full text
    Journal Article
  17. 17

    Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation by Frantsve, J, Schwaller, J, Sternberg, D W, Kutok, J, Gilliland, D G

    Published in Molecular and cellular biology (01-05-2001)
    “…TEL-JAK2 fusion proteins, which are a result of t(9; 12)(p24; p13) translocations associated with human leukemia, activate Stat5 in vitro and in vivo and cause…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Therapeutic intervention in leukemias that express the activated fms-like tyrosine kinase 3 (FLT3): opportunities and challenges by Sternberg, David W, Licht, Jonathan D

    Published in Current opinion in hematology (01-01-2005)
    “…PURPOSE OF REVIEWThe fms-like tyrosine kinase 3 (FLT3) receptor tyrosine kinase is now recognized to be a critical mediator in the pathogenesis of myeloid and…”
    Get full text
    Journal Article
  20. 20

    The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways by Sternberg, D W, Tomasson, M H, Carroll, M, Curley, D P, Barker, G, Caprio, M, Wilbanks, A, Kazlauskas, A, Gilliland, D G

    Published in Blood (01-12-2001)
    “…The TEL/PDGFbetaR gene, which encodes a fusion protein containing the ETS-family member TEL fused to the protein-tyrosine kinase domain of the platelet-derived…”
    Get full text
    Journal Article